APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Outlook and Growth Opportunities 2026

1 May 2026196 pages

Choose your research edition.

Industry ResearchPharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market include SGS, Quanticate, Mercodia, Creative Biolabs, Allucent, IRBM, Pacific BioLabs, Altasciences and Celerion, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market.

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Company

SGS

Quanticate

Mercodia

Creative Biolabs

Allucent

IRBM

Pacific BioLabs

Altasciences

Celerion

Labcorp

Oncodesign Services

Drug Development Solutions

CD BioSciences

Creative-Bioarray

Biotrial

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Type

In Vivo PK and PD Service

PK and PD modelling

DMPK Analysis

Ligand-Binding

Others

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Application

Pharmaceutical Company

Research Institute

Others

Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service key companies, revenue, market share, and recent developments.

3. To split the Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service industry.

Chapter 3: Detailed analysis of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Trends Table 2. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Drivers Table 3. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Opportunities and Challenges Table 4. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Restraints Table 5. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue Share by Company (2021-2026) Table 7. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company, Product Type & Application Table 10. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vivo PK and PD Service Table 15. Significant Companies of PK and PD modelling Table 16. Significant Companies of DMPK Analysis Table 17. Significant Companies of Ligand-Binding Table 18. Significant Companies of Others Table 19. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type (2021-2026) Table 23. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Pharmaceutical Company Table 25. Significant Companies of Research Institute Table 26. Significant Companies of Others Table 27. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application (2021-2026) Table 31. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application (2027-2032) Table 32. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Region (2021-2026) Table 35. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Region (2027-2032) Table 37. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Market Share by Country (2027-2032) Table 42. SGS Company Information Table 43. SGS Business Overview Table 44. SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 46. SGS Recent Development Table 47. Quanticate Company Information Table 48. Quanticate Business Overview Table 49. Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 51. Quanticate Recent Development Table 52. Mercodia Company Information Table 53. Mercodia Business Overview Table 54. Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 56. Mercodia Recent Development Table 57. Creative Biolabs Company Information Table 58. Creative Biolabs Business Overview Table 59. Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 61. Creative Biolabs Recent Development Table 62. Allucent Company Information Table 63. Allucent Business Overview Table 64. Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 66. Allucent Recent Development Table 67. IRBM Company Information Table 68. IRBM Business Overview Table 69. IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 71. IRBM Recent Development Table 72. Pacific BioLabs Company Information Table 73. Pacific BioLabs Business Overview Table 74. Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 76. Pacific BioLabs Recent Development Table 77. Altasciences Company Information Table 78. Altasciences Business Overview Table 79. Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 81. Altasciences Recent Development Table 82. Celerion Company Information Table 83. Celerion Business Overview Table 84. Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 86. Celerion Recent Development Table 87. Labcorp Company Information Table 88. Labcorp Business Overview Table 89. Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 91. Labcorp Recent Development Table 92. Oncodesign Services Company Information Table 93. Oncodesign Services Business Overview Table 94. Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 96. Oncodesign Services Recent Development Table 97. Drug Development Solutions Company Information Table 98. Drug Development Solutions Business Overview Table 99. Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 101. Drug Development Solutions Recent Development Table 102. CD BioSciences Company Information Table 103. CD BioSciences Business Overview Table 104. CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 106. CD BioSciences Recent Development Table 107. Creative-Bioarray Company Information Table 108. Creative-Bioarray Business Overview Table 109. Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 111. Creative-Bioarray Recent Development Table 112. Biotrial Company Information Table 113. Biotrial Business Overview Table 114. Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio Table 116. Biotrial Recent Development Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Image Figure 2. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vivo PK and PD Service Image Figure 8. PK and PD modelling Image Figure 9. DMPK Analysis Image Figure 10. Ligand-Binding Image Figure 11. Others Image Figure 12. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type (2021-2032) Figure 15. Pharmaceutical Company Image Figure 16. Research Institute Image Figure 17. Others Image Figure 18. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application (2021-2032) Figure 21. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo PK and PD Service
  • PK and PD modelling
  • DMPK Analysis
  • Ligand-Binding
  • Others
Applications
  • Pharmaceutical Company
  • Research Institute
  • Others
Companies covered
  • SGS
  • Quanticate
  • Mercodia
  • Creative Biolabs
  • Allucent
  • IRBM
  • Pacific BioLabs
  • Altasciences
  • Celerion
  • Labcorp
  • Oncodesign Services
  • Drug Development Solutions
  • CD BioSciences
  • Creative-Bioarray
  • Biotrial

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Dynamics
  1. 2.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Trends
  2. 2.2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Drivers
  3. 2.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Restraints
3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Company
  1. 3.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Product Type and Application
  6. 3.6 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Type
  1. 4.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Type Introduction
  2. 4.1.1 In Vivo PK and PD Service
  3. 4.1.2 PK and PD modelling
  4. 4.1.3 DMPK Analysis
  5. 4.1.4 Ligand-Binding
  6. 4.1.5 Others
  7. 4.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type
  8. 4.2.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Type (2021-2032)
  10. 4.2.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type (2021-2032)
5 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Application
  1. 5.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Application Introduction
  2. 5.1.1 Pharmaceutical Company
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application
  6. 5.2.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application (2021-2032)
6 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Regional Value Analysis
  1. 6.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Country, 2025 VS 2032
7 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Country-level Value Analysis
  1. 7.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SGS
  2. 8.1.1 SGS Company Information
  3. 8.1.2 SGS Business Overview
  4. 8.1.3 SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  6. 8.1.5 SGS Recent Developments
  7. 8.2 Quanticate
  8. 8.2.1 Quanticate Company Information
  9. 8.2.2 Quanticate Business Overview
  10. 8.2.3 Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  12. 8.2.5 Quanticate Recent Developments
  13. 8.3 Mercodia
  14. 8.3.1 Mercodia Company Information
  15. 8.3.2 Mercodia Business Overview
  16. 8.3.3 Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  18. 8.3.5 Mercodia Recent Developments
  19. 8.4 Creative Biolabs
  20. 8.4.1 Creative Biolabs Company Information
  21. 8.4.2 Creative Biolabs Business Overview
  22. 8.4.3 Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  24. 8.4.5 Creative Biolabs Recent Developments
  25. 8.5 Allucent
  26. 8.5.1 Allucent Company Information
  27. 8.5.2 Allucent Business Overview
  28. 8.5.3 Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  30. 8.5.5 Allucent Recent Developments
  31. 8.6 IRBM
  32. 8.6.1 IRBM Company Information
  33. 8.6.2 IRBM Business Overview
  34. 8.6.3 IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  36. 8.6.5 IRBM Recent Developments
  37. 8.7 Pacific BioLabs
  38. 8.7.1 Pacific BioLabs Company Information
  39. 8.7.2 Pacific BioLabs Business Overview
  40. 8.7.3 Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  42. 8.7.5 Pacific BioLabs Recent Developments
  43. 8.8 Altasciences
  44. 8.8.1 Altasciences Company Information
  45. 8.8.2 Altasciences Business Overview
  46. 8.8.3 Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  48. 8.8.5 Altasciences Recent Developments
  49. 8.9 Celerion
  50. 8.9.1 Celerion Company Information
  51. 8.9.2 Celerion Business Overview
  52. 8.9.3 Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  54. 8.9.5 Celerion Recent Developments
  55. 8.10 Labcorp
  56. 8.10.1 Labcorp Company Information
  57. 8.10.2 Labcorp Business Overview
  58. 8.10.3 Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  60. 8.10.5 Labcorp Recent Developments
  61. 8.11 Oncodesign Services
  62. 8.11.1 Oncodesign Services Company Information
  63. 8.11.2 Oncodesign Services Business Overview
  64. 8.11.3 Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  66. 8.11.5 Oncodesign Services Recent Developments
  67. 8.12 Drug Development Solutions
  68. 8.12.1 Drug Development Solutions Company Information
  69. 8.12.2 Drug Development Solutions Business Overview
  70. 8.12.3 Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  72. 8.12.5 Drug Development Solutions Recent Developments
  73. 8.13 CD BioSciences
  74. 8.13.1 CD BioSciences Company Information
  75. 8.13.2 CD BioSciences Business Overview
  76. 8.13.3 CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  78. 8.13.5 CD BioSciences Recent Developments
  79. 8.14 Creative-Bioarray
  80. 8.14.1 Creative-Bioarray Company Information
  81. 8.14.2 Creative-Bioarray Business Overview
  82. 8.14.3 Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  84. 8.14.5 Creative-Bioarray Recent Developments
  85. 8.15 Biotrial
  86. 8.15.1 Biotrial Company Information
  87. 8.15.2 Biotrial Business Overview
  88. 8.15.3 Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product Portfolio
  90. 8.15.5 Biotrial Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst